心外膜脂肪组织:心血管病防治的新靶点

廖玉华; 余淼; 史河水

doi:10.13201/j.issn.1001-1439.2020.01.002

心外膜脂肪组织:心血管病防治的新靶点

- 1. 华中科技大学同济医学院附属协和医院心内科(武汉, 430022);
- 2. 华中科技大学同济医学院附属协和医院放射科

详细信息

通讯作者: 廖玉华,E-mail:liaoyh27@163.com

中图分类号: R541

收稿日期: 2019-12-09

Epicardial adipose tissue:new target for prevention and treatment of cardiovascular diseases

- 1. Department of Cardiology;
- 2. Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

More Information

Corresponding author: LIAO Yuhua, E-mail: liaoyh27@163.com

Received Date: 09 December 2019

摘要

摘要: 心外膜脂肪组织(EAT)增加心脏代谢风险。高血压、糖尿病、肥胖等危险因素促进EAT积聚,EAT产生促炎症脂肪因子,损害冠状动脉微循环血管,引起心房和心室心肌纤维化、冠状动脉钙化,从而引发心血管病。心脏磁共振是目前测量EAT厚度的重要手段。通过测量EAT厚度有助于判断心房颤动、冠心病和心力衰竭等心血管病预后。抑制EAT形成的药物可以降低心房颤动和心力衰竭的发生发展。
- 心外膜脂肪组织 /
- 促炎症脂肪因子 /
- 心肌纤维化 /
- 心血管危险因素 /
- 心血管病
Abstract: Epicardial adipose tissue(EAT) increases the risk of cardiac metabolism.Hypertension,diabetes,obesity and other risk factors contribute to the accumulation of EAT.The pro-inflammatory fat factors secreted from EAT could lead to the damage of coronary microcirculation vessels,myocardial fibrosis,and calcification of coronary artery,which result in cardiovascular disease.At present,myocardial MRI is an important method to measure the thickness of EAT.EAT thickness measurement is helpful for predicting the prognosis of cardiovascular diseases,such as atrial fibrillation,coronary heart disease and heart failure.Drugs that inhibit the formation of EAT could alleviate the development of atrial fibrillation and heart failure.
- epicardial adipose tissue /
- pro-inflammatory fat factors /
- myocardial fibrosis /
- cardiovascular risk factors /
- cardiovascular disease

HTML全文

参考文献(16)

[1]	Berg G,Miksztowicz V,Morales C,et al.Epicardial adipose tissue in cardiovascular disease[J].Adv Exp Med Biol,2019,1127:131-143.
[2]	Austys D,Dobrovolskij A,Jablonskiené V,et al.Epicardial adipose tissue accumulation and essential hypertension in non-obese adults[J].Medicina(Kaunas),2019,55(8):E456.
[3]	Milanese G,Silva M,Bruno L,et al.Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients:from the ALTER-BIO(Alternative Cardiovascular Bio-Imaging markers)registry[J].Diagn Interv Radiol,2019,25(1):35-41.
[4]	Christensen RH,von Scholten BJ,Hansen CS,et al.Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2diabetes[J].Cardiovasc Diabetol,2019,18(1):114.
[5]	Manno C,Campobasso N,Nardecchia A,et al.Relationship of para-and perirenal fat and epicardial fat with metabolic parameters in overweight and obese subjects[J].Eat Weight Disord,2019,24(1):67-72.
[6]	Packer M.Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium[J].J Am Coll Cardiol,2018,71(20):2360-2372.
[7]	Liu Q,Zhang F,Yang M,et al.Increasing Level of Interleukin-1βin Epicardial Adipose Tissue Is Associated with Persistent Atrial Fibrillation[J].J Interferon Cytokine Res,2019Oct 4.doi:10.1089/jir.2019.0098.
[8]	Packer M.Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation:the potential mediating influence of epicardial adipose tissue[J].Cardiovasc Diabetol,2019,18(1):121.
[9]	Toczylowski K,Hirnle T,Harasiuk D,et al.Plasma concentration and expression of adipokines in epicardial and subcutaneous adipose tissue are associated with impaired left ventricular filling pattern[J].J Transl Med,2019,17(1):310.
[10]	Vianello E,Dozio E,Bandera F,et al.Dysfunctional EAT thickness may promote maladaptive heart remodeling in CVD patients through the ST2-IL33system,directly related to EPAC protein expression[J].Scientific Reports,2019,9(1):10331.
[11]	Zhao YX,Zhu HJ,Pan H,et al.Comparative proteome analysis of epicardial and subcutaneous adipose tissues from patients with or without coronary artery disease[J].Int J Endocrinol,2019,Aug 25.doi:10.1155/2019/6976712.
[12]	张晗晖,孟祥彬,王文光,等.社区人群心外膜脂肪体积与冠心病危险因素和冠状动脉钙化积分的关系[J].中华心血管病杂志,2018,46(5):364-369.
[13]	Pracon R,Kruk M,Kepka C,et al.Epicardial adipose tissue radiodensity is independently related to coronary atherosclerosis.A multidetector computed tomography study[J].Circ J,2011,75(2):391-397.
[14]	Lu C,Jia H,Wang Z.Association between epicardial adipose tissue and adverse outcomes in coronary heart disease patients with percutaneous coronary intervention[J].Biosci Rep,2019,39(5):BSR20182278.
[15]	Packer M.Drugs That ameliorate epicardial adipose tissue inflammation have concordant benefits on atrial fibrillation and on heart failure with a preserved ejection fraction[J].J Card Fail,2019,25(12):986-1003.
[16]	廖玉华、杨杰孚、张健,等.代表中国心肌炎心肌病协作组.舒张性心力衰竭诊断和治疗专家共识[J].临床心血管病杂志,2020,36(1):1-10.